Tevogen Bio Holdings Inc.

Nasdaq:TVGNNasdaq:TVGNW

Biological Products, (No Diagnostic Substances)·WARREN, NJ

CEO

Saadi Ryan H.

CFO

Desai Kirti

Financials

18 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	4/2/25	→
10-Q	Q3 2024	9/30/24	11/19/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

1 shown

Filed	Period
4/26/24	Q1 FY2024	→

News (8-K)

46 shown

Filed	Type	Description
3/4/26	Reg FD	Material Modification to Rights of Security Holders	→
2/25/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/30/26	Reg FD	Regulation FD Disclosure	→
9/26/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
7/10/25	Other	Other Events	→
7/3/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

37 shown

Filed	Form	Description
3/4/26	424B3	424B3	→
2/26/26	424B3	424B3	→
11/14/25	424B3	424B3	→
9/26/25	424B3	424B3	→
8/14/25	424B3	424B3	→
7/10/25	424B3	424B3	→
↓

Filing History(268 filings)

TypeDateAccessionPeriodSize

424B3

Mar 4, 2026

0001493152-26-008790424B3

—

150.8 KB

8-K

Mar 4, 2026

0001493152-26-0087868-K

Mar 3, 2026

364.8 KB

424B3

Feb 26, 2026

0001493152-26-008140424B3

—

52.7 KB

8-K

Feb 25, 2026

0001493152-26-0080658-K

Feb 19, 2026

283.7 KB

144

Feb 6, 2026

0001959173-26-000716

—

5.5 KB

8-K

Jan 30, 2026

0001493152-26-0044618-K

Jan 30, 2026

271.3 KB

DEF 14A

Jan 26, 2026

0001493152-26-003649DEF 14A

Jan 26, 2026

2.6 MB

PRE 14A

Jan 16, 2026

0001493152-26-002646PRE 14A

Dec 31, 2024

2.6 MB

144

Dec 30, 2025

0001959173-25-007935

—

4.4 KB

Dec 22, 2025

0001123292-25-000765STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 18, 2025

5.4 KB

SCHEDULE 13D/A

Dec 16, 2025

0001123292-25-000761

—

6.9 KB

Dec 15, 2025

0001123292-25-000757STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 11, 2025

4.7 KB

Dec 12, 2025

0001123292-25-000755STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 11, 2025

5.4 KB

424B3

Nov 14, 2025

0001493152-25-022644424B3

—

659.8 KB

10-Q

Nov 14, 2025

0001493152-25-02264110-Q

Sep 30, 2025

5.5 MB

424B3

Sep 26, 2025

0001493152-25-015789424B3

—

55.5 KB

8-K

Sep 26, 2025

0001493152-25-0157848-K

Sep 23, 2025

254.9 KB

Aug 18, 2025

0001062993-25-014586STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Aug 15, 2025

5.4 KB

424B3

Aug 14, 2025

0001641172-25-024175424B3

—

681.8 KB

10-Q

Aug 14, 2025

0001641172-25-02410110-Q

Jun 30, 2025

5.5 MB

SCHEDULE 13D/A

Jul 25, 2025

0001641172-25-021070

—

97.3 KB

424B3

Jul 10, 2025

0001641172-25-018535424B3

—

409.4 KB

8-K

Jul 10, 2025

0001641172-25-0185338-K

Jul 10, 2025

252.1 KB

8-K

Jul 3, 2025

0001641172-25-0178738-K

Jul 3, 2025

606.6 KB

424B5

Jul 3, 2025

0001641172-25-017863424B5

—

610.4 KB

25 filings shown

Tevogen Bio Holdings Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(268 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/26/26	DEF 14A	DEF 14A	→
1/16/26	PRE 14A	PRE 14A	→
4/30/25	DEFA14A	FORM DEFA14A	→
4/30/25	DEF 14A	DEF 14A	→
4/25/25	DEFA14A	DEFA14A	→
12/13/23	DEFR14A	DEFR14A	→
↓

Filed	Form	Description
12/22/25	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
12/15/25	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
12/12/25	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
8/18/25	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
7/1/25	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
7/1/25	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
↓

Filed	Form	Description
2/6/26	144	144	→
12/30/25	144	144	→
12/16/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
7/25/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
6/26/25	EFFECT	EFFECT	→
6/9/25	144	144	→
↓